Format

Send to

Choose Destination
See comment in PubMed Commons below
JAMA Cardiol. 2017 Jan 4. doi: 10.1001/jamacardio.2016.5139. [Epub ahead of print]

Types of Myocardial Infarction Among Human Immunodeficiency Virus-Infected Individuals in the United States.

Author information

  • 1Department of Medicine, University of Washington, Seattle.
  • 2Department of Medicine, University of Washington, Seattle2Department of Epidemiology, University of Washington, Seattle.
  • 3Department of Epidemiology, University of Washington, Seattle.
  • 4Department of Medicine, University of California-Los Angeles.
  • 5Department of Medicine, University of Alabama at Birmingham.
  • 6Department of Medicine, University of California-San Diego.
  • 7Department of Medicine, The Johns Hopkins University, Baltimore, Maryland.
  • 8Department of Medicine, The University of North Carolina at Chapel Hill.
  • 9Department of Medicine, University of California-San Francisco.
  • 10Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
  • 11Department of Medicine, University of Washington, Seattle10Department of Biobehavioral Nursing and Health Systems, University of Washington, Seattle.
  • 12Department of Medicine, Northwestern University, Chicago, Illinois.

Abstract

Importance:

The Second Universal Definition of Myocardial Infarction (MI) divides MIs into different types. Type 1 MIs result spontaneously from instability of atherosclerotic plaque, whereas type 2 MIs occur in the setting of a mismatch between oxygen demand and supply, as with severe hypotension. Type 2 MIs are uncommon in the general population, but their frequency in human immunodeficiency virus (HIV)-infected individuals is unknown.

Objectives:

To characterize MIs, including type; identify causes of type 2 MIs; and compare demographic and clinical characteristics among HIV-infected individuals with type 1 vs type 2 MIs.

Design, Setting, and Participants:

This longitudinal study identified potential MIs among patients with HIV receiving clinical care at 6 US sites from January 1, 1996, to March 1, 2014, using diagnoses and cardiac biomarkers recorded in the centralized data repository. Sites assembled deidentified packets, including physician notes and electrocardiograms, procedures, and clinical laboratory tests. Two physician experts adjudicated each event, categorizing each definite or probable MI as type 1 or type 2 and identifying the causes of type 2 MI.

Main Outcomes and Measures:

The number and proportion of type 1 vs type 2 MIs, demographic and clinical characteristics among those with type 1 vs type 2 MIs, and the causes of type 2 MIs.

Results:

Among 571 patients (median age, 49 years [interquartile range, 43-55 years]; 430 men and 141 women) with definite or probable MIs, 288 MIs (50.4%) were type 2 and 283 (49.6%) were type 1. In analyses of type 1 MIs, 79 patients who underwent cardiac interventions, such as coronary artery bypass graft surgery, were also included, totaling 362 patients. Sepsis or bacteremia (100 [34.7%]) and recent use of cocaine or other illicit drugs (39 [13.5%]) were the most common causes of type 2 MIs. A higher proportion of patients with type 2 MIs were younger than 40 years (47 of 288 [16.3%] vs 32 of 362 [8.8%]) and had lower current CD4 cell counts (median, 230 vs 383 cells/┬ÁL), lipid levels (mean [SD] total cholesterol level, 167 [63] vs 190 [54] mg/dL, and mean (SD) Framingham risk scores (8% [7%] vs 10% [8%]) than those with type 1 MIs or who underwent cardiac interventions.

Conclusions and Relevance:

Approximately half of all MIs among HIV-infected individuals were type 2 MIs caused by heterogeneous clinical conditions, including sepsis or bacteremia and recent use of cocaine or other illicit drugs. Demographic characteristics and cardiovascular risk factors among those with type 1 and type 2 MIs differed, suggesting the need to specifically consider type among HIV-infected individuals to further understand MI outcomes and to guide prevention and treatment.

PMID:
28052152
DOI:
10.1001/jamacardio.2016.5139
[PubMed - as supplied by publisher]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems
    Loading ...
    Support Center